Leptin and Melanoma Growth in Mice
Author Information
Author(s): Amjadi Fatemehsadat, Javanmard Shaghaygh Haghjooy, Zarkesh-Esfahani Hamid, Khazaei Majid, Narimani Manijeh
Primary Institution: Isfahan University of Medical Sciences
Hypothesis
Leptin may increase the EPC numbers and NO production in peripheral blood of melanoma tumor bearing mice.
Conclusion
Leptin causes melanoma growth likely through increased nitric oxide production and circulating endothelial progenitor cell numbers.
Supporting Evidence
- Leptin treatment resulted in significantly larger tumors compared to control groups.
- Circulating EPC numbers were significantly higher in leptin-treated mice.
- Plasma levels of nitric oxide were significantly increased in leptin-treated mice.
Takeaway
Leptin, a hormone from fat, helps tumors grow by increasing certain blood cells and chemicals in the body.
Methodology
B16F10 melanoma cells were injected into mice, which were then treated with leptin or control substances, and analyzed for tumor growth and blood samples.
Limitations
The study was conducted in mice, which may not fully represent human responses.
Participant Demographics
Male C57BL/6 mice, aged 6 to 8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website